A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 111.95
GOOG 507.55
MSFT 47.21
FB 78.00
BAC 17.43

Recently Added

GNCMA 12.90
NGL 28.62
DRIV 24.05
MRD 18.63
RCL 78.60

Gaining Speed

RCL 78.60
MRD 18.63
GNCMA 12.90
NGL 28.62
DRIV 24.05

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!